Upload
grace-waters
View
217
Download
2
Embed Size (px)
Citation preview
Good Morning !October 3rd, 2011
Mixed Connective Tissue Disease
An overlap syndrome associated with anti-U1-RNP (ribonucleic protein) antibodies with features of SLE, scleroderma, and polymyositis
In early stages, cannot be differentiated from the other connective tissue diseases (SLE, Scl, PM, DM, RA, and Sjogren’s)
Is MCTD a specific disease?
Early symptoms › Easy fatigability› Poorly defined myalgias› Arthralgias› Raynaud phenomenon
Major reason to consider MCTD a distinct entitiy
For patients with high RNP antibodies:› Seldom develop glomerulonephritis,
cerebritis, psychosis, or seizures› Nearly always have development of
Raynaud phenomenon› More likely to develop pulmonary
hypertension› More likely to be RF positive (in 70%) and
develop erosive arthritis
Clinical features
4 features that suggest MCTD rather than another disorder:› Raynaud and swollen hands› Absence of renal and CNS disease› More severe arthritis› PHTN› RNP antibodies
More common in women (16:1) Present in 2nd or 3rd decade
Clinical features (cont.)
Skin manifestations› Discoid plaques and malar rash
Fever of unknown origin Arthritis is severe
Clinical features (cont.)
Myositis and myalgia
Cardiac disease› RVH› Right atrial enlargement› Conduction defects› Pericarditis (10 to 30%)
Clinical features (cont.)
Pulmonary involvement (75%)› Effusions› PHTN
Screen for with echo› Interstitial lung disease (30 to 50%)
See septal thickening, ground-glass opacities, nonseptal linear opacities, and lower lobe predominance on CT scan
› Infections› Vasculitis
Clinical features (cont.)
Absence of severe renal disease› High titers of RNP antibodies may be
protective GI involvement in 60 to 80%
› Hypomotility› Serositis› Mesenteric vasculitis› Pancreatitis
CNS› Trigeminal neuropathy› Headaches
Lab abnormalities
Low grade anemia Leukopenia Hypergammaglobulinemia RF positive Anti-cyclic citrullinated peptide (CCP)
antibodies + ANA RNP antibodies
Treatment
Thought to be incurable Some features are responsive to
glucocorticoids Antimalrials or methotrexate should be
used in patients requiring repeated or ongoing steroids
Treat specific features (NSAIDS for arthritis, etc.)
Prognosis
Mortality is 16 to 18% at 10 to 12 years Major cause of death is progressive
pulmonary hypertension
Noon ConferenceRadiology